A pilot clinical trial with losartan in Myhre syndrome

INTRODUCTION: Myhre syndrome (MS) is an ultra‐rare disorder due to pathogenic variants in the SMAD4 gene that encodes a protein regulating the TGF‐β pathway and extra‐cellular matrix (ECM) homeostasis. Main clinical features of MS include thickening of skin and joint stiffness. Previous studies show...

Descripción completa

Detalles Bibliográficos
Autores principales: Cappuccio, Gerarda, Caiazza, Martina, Roca, Alessandro, Melis, Daniela, Iuliano, Antonella, Matyas, Gabor, Rubino, Marta, Limongelli, Giuseppe, Brunetti‐Pierri, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898344/
https://www.ncbi.nlm.nih.gov/pubmed/33369056
http://dx.doi.org/10.1002/ajmg.a.62019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898344/
https://www.ncbi.nlm.nih.gov/pubmed/33369056
http://dx.doi.org/10.1002/ajmg.a.62019

Ejemplares similares